Owner Scorecard


← All companies ← AMRN Manual AMRZ → ← AMRN Pharmaceuticals ANAB →

AMRX, Amneal Pharmaceuticals Inc.

Pharmaceuticals consumer brand Cyclical

Amneal Pharmaceuticals Inc. is a diversified, global biopharmaceutical company that develops, manufactures, markets, and distributes a diverse portfolio of essential medicines.

Refer to the section "Segments of the Business" below for an overview of our segments.

Under the ApiJect Agreement, we will install and operate manufacturing equipment leased from Apiject at our Brookhaven, New York facility.

Latest annual: FY2025 10-K
AMRX · Amneal Pharmaceuticals Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$3.0B
+8.0% YoY · 9% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $3.1B 5-yr avg $2.5B
Gross margin 39% 5-yr avg 36%
Operating margin 14.6% 5-yr avg 6.7%
ROIC 18% 5-yr avg 6%
Owner-earnings margin 4% 5-yr avg 8%
Free cash flow margin 4% 5-yr avg 8%

Next report By 11/8 · the 10-Q for the quarter ended late September · due within 40 days of period end · has filed ~37 days after · the wire records it on arrival

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation
Cyclical. Margins collapse and recover repeatedly across the record; a single year, good or bad, misstates the through-cycle earning power.
What moves the needle
Gross margin has run about 37% and operating margin about 7.9% through the cycle, a spread the cycle sets more than the company does. The margin is cyclical, swinging between −15% and 28% over the years, so the through-cycle figure carries more than any single year — and the balance sheet at the trough more than the peak. Inventory runs near 24% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on customer concentration, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has rarely cleared the cost of capital (median 3%, above 15% in 1 of 9 years). By owner earnings: roughly 9% of revenue reaches owners as cash, consistently. The cycle and the balance sheet decide this one; the worst year tells more than the median, and the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMJun 2026
Income statement
$1.0B$1.0B$1.7B$1.6B$2.0B$2.1B$2.2B$2.4B$2.8B$3.0B$3.1BRevenueRevenue
$597M$526M$716M$628M$769M$785M$821M$1.0B$1.1B$1.2BGross profitGross prof.
59%51%44%33%37%35%34%37%37%39%Gross marginGross mgn
12%11%14%18%16%17%18%18%17%17%18%SG&A / revenueSG&A/rev
18%17%12%12%9%10%9%7%7%6%6%R&D / revenueR&D/rev
$285M$245M($20M)($249M)$91M$153M($95M)$204M$249M$394M$454MOperating incomeOp. inc.
28.0%23.7%−1.2%−15.3%4.6%7.3%−4.3%8.5%8.9%13.1%14.6%Operating marginOp. mgn
$215M$171M($203M)($220M)($36M)$31M($248M)($40M)($55M)$139MPretax incomePretax
$0$0($20M)($604M)$68M$13M($271M)($84M)($117M)$72M$157MNet incomeNet inc.
3%1%36%8%-10%Effective tax rateTax rate
Cash flow & returns
$115M$234M$250M$2M$379M$242M$65M$346M$295M$340M$201MOperating cash flowOp. cash
$29M$42M$64M$63M$60M$61M$68M$66M$63M$57MDepreciationDeprec.
$86M$192M$38M$520M$230M$140M$236M$337M$322M$179M$8MWorking capital & otherWC & other
$123M$95M$83M$47M$56M$48M$46M$43M$52M$70M$73MCapexCapex
12.1%9.2%5.0%2.9%2.8%2.3%2.1%1.8%1.9%2.3%2.3%Capex / revenueCapex/rev
$86M$192M$186M($45M)$323M$194M$19M$302M$243M$270M$128MOwner earningsOwner earn.
8.4%18.6%11.2%−2.8%16.2%9.3%0.8%12.6%8.7%8.9%4.1%Owner earnings marginOE mgn
($8M)$139M$167M($45M)$323M$194M$19M$302M$243M$270M$128MFree cash flowFCF
−0.8%13.5%10.1%−2.8%16.2%9.3%0.8%12.6%8.7%8.9%4.1%Free cash flow marginFCF mgn
$0$0$325M$0$251M$147M$85M$0$0$0AcquisitionsAcquis.
$201M$375M$183M$0$0$0Dividends paidDiv. paid
($125M)($99M)($396M)($20M)($318M)($194M)($174M)($69M)($63M)($112M)Investing cash flowInv. cash
($19M)($95M)$288M($46M)$132M($138M)($107M)($213M)($212M)($32M)Financing cash flowFin. cash
$1M($242K)($670K)($2M)$1M$102K($6M)$65K($999K)($2M)Exchange-rate effectFX
($28M)$40M$141M($66M)$194M($90M)($222M)$64M$19M$195MChange in cashΔ cash
9%-1%-7%3%3%-3%7%9%15%18%ROICROIC
-4%-260%22%4%-91%-425%477%Return on equityROE
−40%−260%22%477%Retained to equityRetained/eq
Balance sheet
$27M$74M$213M$151M$341M$248M$26M$92M$111M$282M$128MCash & investmentsCash+inv
$351M$481M$604M$639M$663M$742MReceivablesReceiv.
$284M$457M$381M$491M$489M$531M$581M$612M$606M$678MInventoryInvent.
$70M$115M$103M$153M$131M$166MAccounts payablePayables
$565M$824M$882M$976M$1.0B$1.1B$581M$612M$606M$678MOperating working capitalOper. WC
$772M$1.3B$1.2B$1.6B$1.5B$1.4B$1.4B$1.6B$1.9B$1.9BCurrent assetsCur. assets
$297M$554M$550M$677M$677M$753M$847M$1.1B$882M$883MCurrent liabilitiesCur. liab.
2.6×2.3×2.2×2.3×2.2×1.9×1.6×1.4×2.2×2.2×Current ratioCurr. ratio
$487M$544M$478M$478M$514M$470M$448M$425M$443MNet PP&ENet PP&E
$28M$26M$426M$420M$523M$593M$599M$599M$597M$595M$593MGoodwillGoodwill
$0$4.4B$3.7B$4.0B$3.9B$3.8B$3.5B$3.5B$3.7B$3.8BTotal assetsAssets
$1.4B$2.7B$2.6B$2.8B$2.7B$2.6B$2.4B$2.4B$2.6B$2.6BTotal debtDebt
$1.4B$2.4B$2.5B$2.4B$2.5B$2.6B$2.3B$2.3B$2.3B$2.4BNet debt / (cash)Net debt
$0$12M$17M$25M$41M$65M$77MRedeemable interestsRedeemable
$392M$115M$42M$7M($114M)$230K($245K)($535K)Noncontrolling interestsNCI
$0$505M$232M$303M$360M$298M$20M($109M)($71M)$33MShareholders’ equityEquity
0.0%0.0%10.1%1.3%1.0%1.4%1.4%1.1%1.0%1.1%1.1%Stock comp / revenueSBC/rev
Per share
1.0M127M132M149M152M151M176M309M325M329MShares out (diluted)Shares
$1033.65$13.07$12.31$13.38$13.79$14.66$13.59$9.04$9.29$9.49Revenue / shareRev/sh
$0.00$-0.16$-4.57$0.46$0.09$-1.79$-0.48$-0.38$0.22$0.48EPS (diluted)EPS
$192.22$1.46$-0.34$2.17$1.28$0.12$1.72$0.79$0.83$0.39Owner earnings / shareOE/sh
$139.42$1.31$-0.34$2.17$1.28$0.12$1.72$0.79$0.83$0.39Free cash flow / shareFCF/sh
$375.26$1.44$0.00$0.00$0.00Dividends / shareDiv/sh
$94.77$0.65$0.36$0.38$0.31$0.31$0.25$0.17$0.22$0.22Cap. spending / shareCapex/sh
$0.00$3.97$1.76$2.04$2.37$1.98$0.11$-0.35$-0.22$0.10Book value / shareBVPS

The diluted share count moved ×127.25 into 2018 — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.

The diluted share count moved ×1.75 into 2024 — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.

Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share−44.5%/yr (8-yr)−7.0%/yr
Owner earnings / share−49.4%/yr (8-yr)−17.4%/yr
EPS−13.4%/yr
Capital spending / share−53.3%/yr (8-yr)−10.7%/yr

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2016FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned $72M of profit into $270M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

Reported net income$72M
Owner earnings$270M · 9% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income$72M($117M)($84M)($271M)$13M
Depreciationnon-cash charge added back+$57M+$63M+$66M+$68M+$61M
Amortization of intangible assetsnon-cash charge added back; the purchase price of past acquisitions, expensed over time+$166M+$174M+$163M+$172M+$173M
Stock-based compensationreal costnon-cash, but a real cost+$32M+$28M+$27M+$32M+$28M
Working capital & othertiming of cash in and out, other non-cash items+$12M+$148M+$173M+$64M−$33M
Cash from operations$340M$295M$346M$65M$242M
Capital expenditurecash put back in to keep running and to grow−$70M−$52M−$43M−$46M−$48M
Owner earnings$270M$243M$302M$19M$194M
Owner-earnings marginowner earnings ÷ revenue9%9%13%1%9%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $32M), owner earnings is nearer $238M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Interest expense not tagged in the data
    What this means

    No usable interest-expense line was tagged in the filing data, but the balance sheet carries real net debt — so the interest burden here is unknown, not absent. Read the debt on the net-debt check below.

  • How heavy is the debt, net of cash? $2.3B · 5.8× operating profit
    Heavy net debt
    Cash $282M − debt $2.6B
    What this means

    Netting $282M of cash and short-term investments against $2.6B of debt leaves $2.3B owed, about 5.8× a year's operating profit (6.5× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

Is it a good business?

  • Below average through the cycle
    9-yr median, range -7%–15%; 15% latest = NOPAT $341M ÷ invested capital $2.2B
    Industry peers: median -0%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 9 years (it ran 15% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Solid through the cycle
    10-yr median margin, range -3%–19%; latest $270M = operating cash $340M − maintenance capex $70M
    Industry peers: median 4%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 9% of revenue this year, a 9% median across 10 years. Treating stock comp as the real expense it is (less $32M of SBC) leaves $238M.

  • Cash-backed
    Cash from ops $340M ÷ net income $72M
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 1.22×
    Expanding
    Capex $70M ÷ property depreciation $57M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

The promise and the pay packet

  • Is the buyback buying ownership, or mopping up? 1.1%
    Stock pay, share count unread
    Stock compensation $32M (fiscal 2025), 1.1% of revenue · no repurchases · the share count is not comparable across these years (a split or a first listing sits in the record), so the drift is withheld
    What this means

    Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.

Graham’s defensive tests · 2 of 5 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Pass
    Revenue ≥ $2B · $3.0B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 2.17×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Miss
    Debt ≤ working capital · $2.6B vs $1.0B WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Miss
    A profit every year (10-yr record) · 7 loss years
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record Miss
    Uninterrupted dividends · 3 of 10 yrs
    What this means

    An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.

  • Earnings growth
    Earnings +33% over the record ·
    What this means

    Earnings were negative early in the record, a growth rate isn't meaningful.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-0.13/share (latest year $0.23), the averaged base the calculator's gate runs on, and book value is $-0.22/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 3 of 10
    What this means

    Lost money in 7 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 1 of 9 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 17% → 10% (3-yr avg ends)

    In the filing’s words The words explain the slip: the filing names price competition rather than pricing actions of its own — a business that looks to take its price, not set it.

    What this means

    Through the cycle the operating margin slipped — about 17% early to 10% lately, median 7% — competition or costs are biting in.

  • Reinvestment, incremental ROIC returns capital
    What this means

    The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.

  • Owner earnings growth +7%/yr
    What this means

    Owner earnings grew about 7% a year over the record.

  • Worst year 2019 · −15.3% op. margin
    What this means

    Operations went underwater in 2019, understand why before trusting the good years.

  • Dividend record paid
    What this means

    Paid a dividend in 3 of the years on record.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Jun 30, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$1.9B
  • Cash & short-term investments$128M
  • Inventory$678M
  • Other current assets$1.1B
Current liabilities$883M
  • Debt due within a year$6M
  • Other current liabilities$877M
Current ratio2.20×all current assets ÷ what's due · Graham looked for 2×
Quick ratio1.44×stricter: inventory excluded
Cash ratio0.14×strictest: cash alone against what's due
Working capital$1.1Bthe cushion left after near-term bills
Debt due this year vs. cash$6M due · $128M cash covered by cash on hand, no refinancing forced · both figures from the Jun 30, 2026 balance sheet
Revenue, latest quarter vs. a year ago+9.9%the freshest read on whether the business is still growing
Current ratio, recent quarters1.4× → 2.2×
Deeper floors
Tangible book value($1.1B)equity stripped of goodwill & intangibles
Debt incl. operating leases$2.6Bno operating-lease liability tagged this quarter, so debt alone

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $2.3B of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.

  • Reinvested$664M · 29%
  • Dividends$759M · 33%
  • Retained (debt / cash)$845M · 37%
  • Returned to owners$759M

    43% of the owner earnings the business produced over the span, $759M as dividends and $0 as buybacks.

  • Net change in share count32752.7%

    The diluted count rose from 1M to 329M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.

  • Dividend record$0.00/sh

    Paid in 3 of the years on record. It was cut at least once along the way.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$1.2B32% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equitygoodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$807Mover 9 years since fiscal 2016 buying other businesses, against $664M of capital spent building over the 10-year record

$9M written down across 2 years (2017, 2019): goodwill the company has already conceded it overpaid for, charged against earnings. A write-down costs no cash (the cash went out when the deal was signed), but it is management marking its own past judgment to market.

Beside that spending sits $1.4B of cumulative amortization of acquired intangibles charged against earnings since fiscal 2016 — the purchase price of past deals, expensed over time.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and amortization summed across the company's full tagged history, write-downs across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2022Chintu Patel$5.1M−$1.8M$19M
2022Chirag Patel$5.0M−$1.8M$19M
2023Chintu Patel$2.4M$9.5M$302M
2023Chirag Patel$2.4M$9.5M$302M
2024Chintu Patel$7.2M$11.9M$243M
2024Chirag Patel$7.2M$11.9M$243M
2025Chintu Patel$8.7M$24.4M$270M
2025Chirag Patel$8.7M$24.3M$270M

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Stock-based compensation$32M

    The slice of the business handed to employees in shares in fiscal 2025, 1.1% of revenue, equal to 8.1% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • How much of the revenue rides on one buyer?
    ≈$2.2B · 71% of revenue on the largest customers (TTM)
    “For the year ended December 31, 2025, our four largest customers, Cencora, Inc., McKesson Drug Co., Cardinal Health, Inc., and CVS Health Corporation, collectively accounted for approximately 71% of our consolidated net revenue.”verify →
  • Which reported numbers are a judgment call?
    Management names Income taxes, Acquisitions as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Pharmaceuticals

The same industry, side by side on owner economics. Each column names the period it is read over; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
ELANElanco Animal Health Incorporated$4.7B54%-1.2%-0%4%
JAZZJazz Pharmaceuticals$4.3B16.8%8%35%
PRGOPerrigo Company plc$4.3B36%3.9%1%6%
ALNYAlnylam$3.7B86%-79.8%-83%-69%
BMRNBioMarin$3.2B78%-1.7%-1%1%
UTHRUnited Therapeutics$3.2B92%47.5%20%39%
AMRXAmneal Pharmaceuticals Inc.$3.0B37%7.9%3%9%
SRPTSarepta$2.2B-65.5%-25%-44%
Group median66%1.3%1%5%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Amneal Pharmaceuticals Inc. has delivered.

$

Through the cycle, Amneal Pharmaceuticals Inc. earns about $275M on its 9.1% median owner-earnings margin. This year’s 8.9% margin runs in line with that. Normalize, below, values the price on that through-cycle figure rather than the latest year.

Base

The assumptions

9.0% = the 4.65% 10-year Treasury (Aug 19, 2026) + 4.35 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’21→’25+25%/yr
Owner-earnings growth · ’16→’25+16%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.65%, as of Aug 19, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings $128M on 319M shares outstanding, per the 10-Q cover, as of 2026-07-31; net debt $2.4B. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "Amneal Pharmaceuticals Inc. (AMRX), the owner's record," https://ownerscorecard.com/c/AMRX, data as of 2026-08-17.

Manual order: ← AMRN its page in the Manual AMRZ →

Industry order: ← AMRN the Pharmaceuticals chapter ANAB →